NCT04359264UnknownNot Applicable
Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial (DISTANSE COVID-19 RCT)
Conditions
Interventions
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Unity Health Toronto
- Enrollment
- 392
- Locations
- 2
- Primary Endpoint
- Symptoms consisent with COVID-19
Study Overview
Brief Summary
This is a clinical trial of a cash transfer on symptoms consistent with COVID-19 and adherence to physical distancing guidance.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Prevention
- Masking
- Double (Investigator, Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •trouble "making ends meet at the end of the month" due to COVID-19 related disruptions
Exclusion Criteria
- •confirmed positive for COVID-19 based on laboratory testing
- •current symptoms consistent with COVID-19
Arms & Interventions
Cash transfer
Experimental
Intervention: Cash transfer (Other)
Control
No Intervention
Outcomes
Primary Outcomes
Symptoms consisent with COVID-19
Time Frame: 14 days
32-item Influenza Patient-reported Outcome (FLU-PRO) symptom score. Higher score is worse.
Secondary Outcomes
- Self-reported health based on the single question: "In general, would you say your health is.."(14 days)
- Ability to make ends meet based on the single question: "At the end of the month, are you able to make ends meet?"(14 days)
- Number of close contacts(Sum of contacts on days 5, 10 and 14)
- Number of participants with positive test for COVID-19(14 days)
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Active, not recruiting
Phase 1
se of Tocilizumab in the inflammatory phase of COVID-19 / new coronavirus diseaseCOVID-19 / new coronavirus diseaseMedDRA version: 23.0Level: LLTClassification code 10084382Term: Coronavirus disease 2019System Organ Class: 100000004862EUCTR2020-002039-31-FITurku University Hospitla90
Unknown
Phase 3
Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the GambiaCovid-19NCT04703608London School of Hygiene and Tropical Medicine1,200
Recruiting
Phase 1
Covid-19 and Influenza Oral Vaccine Studycovid19 InfectionInfluenza, HumanNCT06355232Vaxine Pty Ltd100
Active, not recruiting
Unknown
HS COVID-related post-traumatic stress disorder (PTSD) experimental treatment trialPost-Traumatic Stress Disorder (PTSD)Mental and Behavioural DisordersISRCTN52834682King's College London18
Completed
Not Applicable
Financial Incentives for Medication AdherenceHyperlipidemiaHypertensionDiabetes MellitusNCT01678183Boston Medical Center74